Freenome
6 known investors
Freenome develops early-stage cancer detection technology using blood tests to identify cancer in its earliest, most treatable phases. The company serves healthcare providers and patients seeking preventive cancer screening solutions.
Founders & leadership
RE
Riley EnnisCo-Founder and Chief Product Officer